Company intelligence / Profile preview
Wntrix Inc.
Houston, Texas, United Stateswntrix.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Wntrix Inc. has not yet reported clinical results, as all programs are at the preclinical stage. The company focuses on developing ADCs against novel targets for advanced-stage solid tumors, with initial programs targeting lung, liver, and kidney cancers. No human data or IND filings have been announced as of May 2025.[1][2][4][6]
Pipeline Breadth
Wntrix has at least three preclinical ADC programs:
| name | stage | modality | target | indication | |--------|-------------|--------------------------|----------------|----------------| | WTX301 | Preclinical | Antibody drug conjugate | Not disclosed | Lung Cancer | | WTX201 | Preclinical | Antibody drug conjugate | Not disclosed | Liver Cancer | | WTX202 | Preclinical | Antibody drug conjugate | Not disclosed | Kidney Neoplasms| [6]- Therapeutic areas
- GastroenterologyOncologyDermatology
- Modalities
- Antibody Drug Conjugates (ADC)
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Beyond the preview
Go deeper on Wntrix Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Wntrix Inc..